Predictors of macular edema recurrence and visual outcomes in branch retinal vein occlusion treated with aflibercept or ranibizumab. Chang JT, Chien HW, Hsieh YT, Liu KR, et al. Int Ophthalmol 2025;45:96.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chang JT, Chien HW, Hsieh YT, Liu KR, et al. Predictors of macular edema recurrence and visual outcomes in branch retinal vein occlusion treated with aflibercept or ranibizumab. Int Ophthalmol 2025;45:96.
PMID: 40085265